Julz

Calcivis is a privately held company founded in 2012 and headquartered in Edinburgh, Scotland. It specializes in developing and commercializing innovative dental imaging technology aimed at addressing significant unmet needs in dentistry. The company's core product is a platform designed to revolutionize the treatment of tooth decay by enabling dentists to visualize active decay early, potentially preventing cavities that would otherwise require drilling and filling. Calcivis operates a virtual development model, collaborating with contract research and manufacturing organizations predominantly based in Scotland.

PhotoniCare, Inc. is a medical device company based in Champaign, Illinois, founded in 2013. The company specializes in developing innovative diagnostic tools for middle ear infections, particularly through its flagship product, the TOMi Scope. This handheld device utilizes advanced light-based technology, specifically near-infrared light waves, to provide 3D visualization of the middle ear beyond the eardrum. By enabling physicians to directly and harmlessly visualize the middle ear, PhotoniCare's technology allows for rapid assessment of middle ear conditions, assisting in determining the appropriate treatment, whether it be antibiotics or surgical intervention. The company's imaging platform also presents potential for future growth beyond otology.

SurgaColl Technologies Ltd., established in 2010 and headquartered in Cork, Ireland, is a medical devices company specializing in the development, production, and marketing of innovative tissue regeneration products. These products, based on technology originating from the Royal College of Surgeons in Ireland, support the body's natural healing processes. SurgaColl's portfolio includes HydroxyColl, a bone graft substitute, and ChondroColl, a biomimetic scaffold for osteochondral defect repair. The company's mission is to lead the field of regenerative medical devices, promoting faster tissue regeneration and enabling patients to return to a healthy, active lifestyle.

Calcivis is a privately held company founded in 2012 and headquartered in Edinburgh, Scotland. It specializes in developing and commercializing innovative dental imaging technology aimed at addressing significant unmet needs in dentistry. The company's core product is a platform designed to revolutionize the treatment of tooth decay by enabling dentists to visualize active decay early, potentially preventing cavities that would otherwise require drilling and filling. Calcivis operates a virtual development model, collaborating with contract research and manufacturing organizations predominantly based in Scotland.

Pathfinder Medical is focused on developing an innovative electronic guidance system that allows clinicians to connect blood vessels through minimally invasive techniques. This novel catheter-based technology is specifically designed for vascular access creation, addressing critical needs in the treatment of kidney failure, particularly for patients requiring hemodialysis. The system is engineered to be performed outside of the operating room, reducing the likelihood of complications and enhancing patient care. Pathfinder Medical's platform has significant potential across various clinical applications, including bypassing peripheral blockages, and operates within a substantial market valued at £1.6 billion annually.